The Difficulties of Multiple Drug Safety Reporting
Polypharmacy, which is commonly described as taking five or more prescriptions daily, has become a common occurrence in society, especially among the elderly who are frequently given a variety of various medications.
Despite the fact that estimates for polypharmacy differ, the practice is becoming common. One UK study found that over the past 20 years, from 12 to 49 percent, the proportion of adults over 65 who take five or more medications—both prescription and over-the-counter—has nearly doubled. Another study that concentrated on elderly people living in nursing homes discovered that 91% of them were taking more than five medications, and 66% were taking more than ten.
Without a doubt, having access to medications has reduced the burden of symptoms while saving many lives. However, polypharmacy itself has the potential to be problematic. Prescriptions may lengthen over time when a person needs more medical attention, as Elen Jones, director for Wales at the Royal Pharmaceutical Society, says. Even after they are no longer needed, medications frequently remain on prescriptions.
When reducing the number of medications might be preferable, a person may occasionally be prescribed a prescription to address the side effects of another medication. In other situations, their healthcare may be disjointed, with various prescriptions arriving from various specialists who don’t communicate with one another. Such circumstances frequently result in worse outcomes.
The risk of drug interactions:
The potential for drug-drug interactions is one of the main issues with polypharmacy (DDIs). The interactions between two or more drugs can occasionally affect both efficacy and safety when they are taken together. One estimate suggests that DDIs may account for 30% of negative medication responses (ADRs).
It can be increasingly challenging to keep track of all the many potential interactions the more medications a person takes. This is particularly true when there is a lack of coordination between healthcare providers or when the patient is secretive about their medication intake.
Drug safety and polypharmacy:
When negative effects do occur, it might be challenging to determine what led to them. Was it brought on by medicine X, drug Y, or a combination of the two? This issue is made worse by the fact that the symptoms of polypharmacy are frequently mistaken for age-related problems like fatigue, digestive issues, confusion, depression, and so forth.
The first step in pharmacovigilance in this area, despite the fact that it isn’t always simple, is to report any suspected ADRs, regardless of what caused them. This entails reporting to the FDA’s Adverse Event Reporting System in the US, while in the UK, reporting is done through the Yellow Card Scheme of the Medicines and Healthcare Products Regulatory Agency.
There is potential to employ data mining methods to more fully understand the causes of ADRs after they are logged into the system. Data scientists may filter through mountains of data to highlight potential drug-drug interactions using new informatics-driven methodologies. Researchers can use their technologies to mine scholarly literature and even social media in addition to pharmacovigilance data.
Although these methods show promise for improving our understanding of DDIs, it is simply not practical to consider all potential drug combinations. In addition, older persons are frequently underrepresented in scientific research. As a result, the results might not correctly reflect the population’s use of these medications. Because of this, the dangers of excessive polypharmacy must be addressed separately.
Clearly, both improved safety reporting using suitable data mining technologies and a general decrease in hazardous polypharmacy are needed. When used properly, polypharmacy can increase the quality of life and increase life expectancy, but it’s necessary to weigh the risks with the rewards. It will be essential to attack this problem from all directions because doctors are prescribing patients more and more medications.
The Difficulties of Multiple Drug Safety Reporting
Polypharmacy, which is commonly described as taking five or more prescriptions daily, has become a common occurrence in society, especially among the elderly who are frequently given a variety of various medications.
Despite the fact that estimates for polypharmacy differ, the practice is becoming common. One UK study found that over the past 20 years, from 12 to 49 percent, the proportion of adults over 65 who take five or more medications—both prescription and over-the-counter—has nearly doubled. Another study that concentrated on elderly people living in nursing homes discovered that 91% of them were taking more than five medications, and 66% were taking more than ten.
Without a doubt, having access to medications has reduced the burden of symptoms while saving many lives. However, polypharmacy itself has the potential to be problematic. Prescriptions may lengthen over time when a person needs more medical attention, as Elen Jones, director for Wales at the Royal Pharmaceutical Society, says. Even after they are no longer needed, medications frequently remain on prescriptions.
When reducing the number of medications might be preferable, a person may occasionally be prescribed a prescription to address the side effects of another medication. In other situations, their healthcare may be disjointed, with various prescriptions arriving from various specialists who don’t communicate with one another. Such circumstances frequently result in worse outcomes.
The risk of drug interactions:
The potential for drug-drug interactions is one of the main issues with polypharmacy (DDIs). The interactions between two or more drugs can occasionally affect both efficacy and safety when they are taken together. One estimate suggests that DDIs may account for 30% of negative medication responses (ADRs).
It can be increasingly challenging to keep track of all the many potential interactions the more medications a person takes. This is particularly true when there is a lack of coordination between healthcare providers or when the patient is secretive about their medication intake.
Drug safety and polypharmacy:
When negative effects do occur, it might be challenging to determine what led to them. Was it brought on by medicine X, drug Y, or a combination of the two? This issue is made worse by the fact that the symptoms of polypharmacy are frequently mistaken for age-related problems like fatigue, digestive issues, confusion, depression, and so forth.
The first step in pharmacovigilance in this area, despite the fact that it isn’t always simple, is to report any suspected ADRs, regardless of what caused them. This entails reporting to the FDA’s Adverse Event Reporting System in the US, while in the UK, reporting is done through the Yellow Card Scheme of the Medicines and Healthcare Products Regulatory Agency.
There is potential to employ data mining methods to more fully understand the causes of ADRs after they are logged into the system. Data scientists may filter through mountains of data to highlight potential drug-drug interactions using new informatics-driven methodologies. Researchers can use their technologies to mine scholarly literature and even social media in addition to pharmacovigilance data.
Although these methods show promise for improving our understanding of DDIs, it is simply not practical to consider all potential drug combinations. In addition, older persons are frequently underrepresented in scientific research. As a result, the results might not correctly reflect the population’s use of these medications. Because of this, the dangers of excessive polypharmacy must be addressed separately.
Clearly, both improved safety reporting using suitable data mining technologies and a general decrease in hazardous polypharmacy are needed. When used properly, polypharmacy can increase the quality of life and increase life expectancy, but it’s necessary to weigh the risks with the rewards. It will be essential to attack this problem from all directions because doctors are prescribing patients more and more medications.
Recent Posts
Popular Categories